A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind

Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.

Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.

malaria treatment
Infographic: Fighting Malaria Drug Resistance
Infographic: Fighting Malaria Drug Resistance
Natalie Slivinski | Feb 28, 2019
The parasite that causes malaria has evolved to evade many of the drugs that researchers have developed to fight the tropical disease.
Are We Headed for a New Era of Malaria Drug Resistance?
Are We Headed for a New Era of Malaria Drug Resistance?
Natalie Slivinski | Feb 28, 2019
Plasmodium falciparum has shown an ability to evade everything we throw at it, most recently artemisinin-based combination therapies, today’s front-line treatment.